Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MAYNE PHARMA GROUP LIMITED Capital/Financing Update 2007

Jun 26, 2007

65396_rns_2007-06-26_4e93de9f-1194-48bd-9f27-ec53f0fd0e3e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Circular CO
ΗA
Date: 27 June, 2007 Halcy
Key topics
1. HalcyGen Pharmaceuticals
of AS
Emred
2. ASX Code: HGN
Offic
2007
3. Quotation commences: 11.00
AM EST, Friday 29 June 2007.
Quot
Reading List
Banks
Client Advisers
Compliance Managers
Corporate Advisory
DTH Operators
Issuers
institutions
ASTC Participants
Operations Managers (back
office)
Share Registries
ACH Participants
Market Participants
Contact
Kate Kidson
Telephone
(03) 9617 7831
ASX Limited
ABN 98 008 624 691
Exchange Centre
20 Bridge Street
Sydney NSW 2000
PO Box H224
Australia Square NSW 1215
Internet: http://www.asx.com.au
Divid

MMENCEMENT OF OFFICIAL QUOTATION -LCYGEN PHARMACEUTICALS LIMITED

yGen Pharmaceuticals Limited (the "Company") was admitted to the official list SX Limited on Wednesday, 27 June 2007.

ial quotation of the Company's securities will commence on Friday, 29 June

ed Securities: 34,421,200 ordinary shares fully paid Code: HGN 11.00 AM EST Ľ, Friday, 29 June 2007 Abbreviation: HalcyGen AU000000HGN8 e Branch: Melbourne TBA stry Classification: stered Office: Level 10 470 Collins Street Melbourne, VIC 3000 Phone:- (03) 8614 7777 Fax:- (03) 9614 7022 pany Secretary: Aaron Finlay Computershare Investor Services Pty e Registry: Ltd Level 2 45 St Georges Terrace Perth WA 6000 Tolhurst Limited nwriter to the issue: 30 June nce Date: SS: Participating. The Company will also operate an issuer sponsored subregister. Western Australia e of Incorporation: restricted securities: See below See page 48 of the prospectus dated 23 lend Policy: May 2007.

Activities:

Securities not quoted:

The testing and improvement of generic drugs.

22,295,000 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a of 24 period months from commencement of official quotation.

3,250,000 options exercisable at 10 cents each on or before 30 June 2010 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.

1,625,000 options exercisable at 60 cents each on or before 17 April 2011 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.

1,375,000 options exercisable at 60 cents each on or before 17 April 2012 classified by ASX as restricted securities and to be held in escrow for 24 months from commencement of official quotation.

17,782,800 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a period of 12 months from the date of issue being 18 September 2006.

1,600,000 ordinary shares fully paid classified by ASX as restricted securities and to be held in escrow for a period of 12 months from the date of issue being 18 February 2007.